Exheus
Developed a technology that analyses gene expression and its alterations, through artificial intelligence, to optimize people’s performance, health and nutrition.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Nov 2022.)
Company register number B01686518
Barcelona Catalonia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Spinout | ||
N/A | Support Program | ||
* | N/A | - | |
* | €900k | Seed | |
| Total Funding | €900k | ||
Related Content
Recent News about Exheus
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.